Reneo Pharmaceuticals, Inc. - Class A Common Stock (RPHM)
1.8200
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 3rd, 9:50 AM EDT

Via Benzinga · September 17, 2024

RPHM stock results show that Reneo Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 13, 2024

Via Benzinga · May 28, 2024

Via Benzinga · December 15, 2023

Via Benzinga · May 17, 2024

Reneo and Onkure announced Monday that they have entered into a definitive merger agreement to combine the two companies in an all-stock transaction.
Via Benzinga · May 13, 2024

RPHM stock results show that Reneo Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 7, 2024

RPHM stock results show that Reneo Pharmaceuticals missed analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · March 28, 2024

Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per share. Reneo Pharmaceuticals shares climbed 13.6% to $1.59 on Wednesday.
Via Benzinga · December 27, 2023

Shares of Ascent Industries Co. (NASDAQ: ACNT) rose sharply in pre-market trading as the company reported the sale of the business of Specialty Pipe & Tube for around $55 million in an all-cash deal. Ascent Industries shares surged 7.4% to $8.69 in pre-market trading.
Via Benzinga · December 27, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning lower on Thursday. The Dow traded up 0.04% to 37,105.00 while the NASDAQ fell 0.44% to 14,669.25. The S&P 500 also fell, dropping, 0.10% to 4,702.57.
Via Benzinga · December 14, 2023

Via Benzinga · December 14, 2023

Reneo Pharmaceuticals Inc (NASDAQ: RPHM) shares are sinking after the company released data from its pivotal STRIDE Phase 2b study of mavodelpar in adult patients with primary mitochondrial myopathies (PMM), a group of mitochondrial diseases that cause
Via Benzinga · December 14, 2023

Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales guidance below estimates.
Via Benzinga · December 14, 2023

Via Benzinga · August 28, 2023

Via Benzinga · July 18, 2023

Via Benzinga · July 3, 2023

Although US stocks closed mixed on Wednesday, there were a few notable insider trades.
Via Benzinga · May 11, 2023

Via Benzinga · May 4, 2023

Gainers Almaden Minerals Ltd. (NYSE: AAU) gained 72.3% to $0.2111 in pre-market trading after gaining 2% on Wednesday.
Via Benzinga · May 4, 2023